Augmented Intelligence for Clinical Discovery in Hypertensive Disorders of Pregnancy Using Outlier Analysis
- PMID: 37009347
- PMCID: PMC10065308
- DOI: 10.7759/cureus.36909
Augmented Intelligence for Clinical Discovery in Hypertensive Disorders of Pregnancy Using Outlier Analysis
Abstract
Objectives Clinical discoveries are heralded by observing unique and unusual clinical cases. The effort of identifying such cases rests on the shoulders of busy clinicians. We assess the feasibility and applicability of an augmented intelligence framework to accelerate the rate of clinical discovery in preeclampsia and hypertensive disorders of pregnancy-an area that has seen little change in its clinical management. Methods We conducted a retrospective exploratory outlier analysis of participants enrolled in the folic acid clinical trial (FACT, N=2,301) and the Ottawa and Kingston birth cohort (OaK, N=8,085). We applied two outlier analysis methods: extreme misclassification contextual outlier and isolation forest point outlier. The extreme misclassification contextual outlier is based on a random forest predictive model for the outcome of preeclampsia in FACT and hypertensive disorder of pregnancy in OaK. We defined outliers in the extreme misclassification approach as mislabelled observations with a confidence level of more than 90%. Within the isolation forest approach, we defined outliers as observations with an average path length z score less or equal to -3, or more or equal to 3. Content experts reviewed the identified outliers and determined if they represented a potential novelty that could conceivably lead to a clinical discovery. Results In the FACT study, we identified 19 outliers using the isolation forest algorithm and 13 outliers using the random forest extreme misclassification approach. We determined that three (15.8%) and 10 (76.9%) were potential novelties, respectively. Out of 8,085 participants in the OaK study, we identified 172 outliers using the isolation forest algorithm and 98 outliers using the random forest extreme misclassification approach; four (2.3%) and 32 (32.7%), respectively, were potential novelties. Overall, the outlier analysis part of the augmented intelligence framework identified a total of 302 outliers. These were subsequently reviewed by content experts, representing the human part of the augmented intelligence framework. The clinical review determined that 49 of the 302 outliers represented potential novelties. Conclusions Augmented intelligence using extreme misclassification outlier analysis is a feasible and applicable approach for accelerating the rate of clinical discoveries. The use of an extreme misclassification contextual outlier analysis approach has resulted in a higher proportion of potential novelties than using the more traditional point outlier isolation forest approach. This finding was consistent in both the clinical trial and real-world cohort study data. Using augmented intelligence through outlier analysis has the potential to speed up the process of identifying potential clinical discoveries. This approach can be replicated across clinical disciplines and could exist within electronic medical records systems to automatically identify outliers within clinical notes to clinical experts.
Keywords: augmented intelligence; clinical discovery; clinical trials; hdp; hypertensive disorders of pregnancy; preeclampsia treatment; preeclampsia-eclampsia; real-world data; research methods and design.
Copyright © 2023, Janoudi et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Outlier analysis for accelerating clinical discovery: An augmented intelligence framework and a systematic review.PLOS Digit Health. 2024 May 22;3(5):e0000515. doi: 10.1371/journal.pdig.0000515. eCollection 2024 May. PLOS Digit Health. 2024. PMID: 38776276 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Data-driven evolution of water quality models: An in-depth investigation of innovative outlier detection approaches-A case study of Irish Water Quality Index (IEWQI) model.Water Res. 2024 May 15;255:121499. doi: 10.1016/j.watres.2024.121499. Epub 2024 Mar 20. Water Res. 2024. PMID: 38552494
-
Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. PMID: 24783270 Free Books & Documents. Review.
-
Dietary Patterns before and during Pregnancy and Risk of Hypertensive Disorders of Pregnancy: A Systematic Review [Internet].Alexandria (VA): USDA Nutrition Evidence Systematic Review; 2019 Apr. Alexandria (VA): USDA Nutrition Evidence Systematic Review; 2019 Apr. PMID: 35503867 Free Books & Documents. Review.
Cited by
-
Outlier analysis for accelerating clinical discovery: An augmented intelligence framework and a systematic review.PLOS Digit Health. 2024 May 22;3(5):e0000515. doi: 10.1371/journal.pdig.0000515. eCollection 2024 May. PLOS Digit Health. 2024. PMID: 38776276 Free PMC article.
References
-
- Pre-eclampsia. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Lancet. 2010;376:631–644. - PubMed
LinkOut - more resources
Full Text Sources